Second report from an anaesthetic reactions advisory service

Area of Science:

• Anesthesiology
• Pharmacovigilance
• Clinical Toxicology

Background:

• Advisory services play a crucial role in monitoring and reporting adverse drug reactions (ADRs).
• Understanding trends in ADRs is vital for patient safety in clinical practice.
• Previous data highlighted thiopentone as a significant contributor to adverse events.

Purpose of the Study:

• To report on the continued work of an advisory service concerning clinically severe adverse reactions.
• To identify the most frequently implicated agents in severe adverse reactions.
• To analyze the association of specific agents, particularly intravenous induction agents, with adverse events.

Main Methods:

• Analysis of enquiry data from an ongoing advisory service.
• Categorization of adverse reactions based on causative agents.
• Quantification of reported incidents linked to specific drugs and drug combinations.

Main Results:

• The advisory service handles at least 300 enquiries annually regarding clinically severe adverse reactions.
• Thiopentone is identified as the most common intravenous induction agent associated with adverse reactions, accounting for 76% of reports.
• Local anesthetics represent a smaller proportion, between 5% and 10%, of reported adverse reactions.

Conclusions:

• Thiopentone, particularly when co-administered with suxamethonium, continues to be a primary concern for severe adverse reactions during anesthesia.
• Ongoing vigilance and reporting through advisory services are essential for pharmacovigilance.
• Further investigation into the mechanisms and prevention of thiopentone-induced adverse reactions is warranted.